GO:0022883 zinc efflux transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0022883 describes the molecular function of moving zinc ions from the inside of a cell to the outside across a membrane.
• The SLC30A (ZnT) family, including SLC30A1 (ZnT1), SLC30A10, and the non-SLC30A protein TMEM163, are established zinc efflux transporters.
• Zinc efflux is essential for cellular zinc homeostasis, protecting cells from zinc toxicity and supplying zinc to extracellular processes.
• Somatic mutations in SLC30A1 cause aldosterone-producing adenomas and primary aldosteronism, directly linking zinc efflux to human endocrine disease.
• Zinc efflux can be studied with radioactive zinc flux assays, fluorescent zinc probes, electrophysiology, and CRISPR-engineered cell models.
• CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of zinc efflux genes in disease and physiology.
Description
Zinc is an essential trace element that serves as a catalytic cofactor and structural component of thousands of proteins, but free zinc is also toxic when it accumulates inside cells. To maintain a narrow window of intracellular zinc, cells use dedicated transport proteins that move zinc across membranes. The Gene Ontology term GO:0022883, zinc efflux transmembrane transporter activity, captures the molecular function of transferring a zinc ion or zinc ions from the inside of the cell to the outside across a membrane. This activity is distinct from zinc uptake and from intracellular zinc sequestration, and it is carried out by members of the SLC30A (ZnT) family and related proteins. Researchers study zinc efflux because it sits at the intersection of metal homeostasis, cell signaling, and disease. For example, somatic mutations in SLC30A1, which encodes the zinc transporter ZnT1, alter zinc efflux and cause aldosterone-producing adenomas and primary aldosteronism. TMEM163 has been shown to efflux zinc and is implicated in cellular zinc handling. Structural and biochemical work on SLC30A10 has revealed how transmembrane and cytoplasmic domains cooperate to transport metal ions, providing a framework for understanding related zinc transporters. This article summarizes the authoritative definition of GO:0022883, the biological processes and molecular mechanisms behind zinc efflux, the key genes and proteins involved, and the experimental methods, including CRISPR-based models, that are used to study this activity in health and disease.
zinc efflux transmembrane transporter activity At A Glance
| GO ID | GO:0022883 |
|---|---|
| GO term | zinc efflux transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | zinc efflux permease activity |
| Definition | Enables the transfer of a zinc ion or zinc ions from the inside of the cell to the outside of the cell across a membrane. |
| Major function | Export of intracellular zinc to the extracellular space to maintain zinc homeostasis and prevent zinc toxicity. |
| Representative proteins | SLC30A1 (ZnT1), SLC30A10, TMEM163, and other SLC30A/ZnT family members. |
| Transport mode | Secondary active or facilitated diffusion, with some members acting as sodium-zinc exchangers or proton-coupled transporters. |
| Disease relevance | Somatic SLC30A1 mutations cause aldosterone-producing adenomas and primary aldosteronism. |
What Is GO:0022883?
GO:0022883, zinc efflux transmembrane transporter activity, is a molecular function defined as enabling the transfer of a zinc ion or zinc ions from the inside of the cell to the outside of the cell across a membrane. In practice, this means a protein or protein complex binds intracellular zinc and moves it across a lipid bilayer to the extracellular space, often against a concentration gradient or in exchange for another ion. The synonym zinc efflux permease activity reflects this transport role. This term describes the transport activity itself, not the upstream signaling or downstream physiological consequences, although those consequences are often what researchers measure.
Why Is zinc efflux transmembrane transporter activity Important in Cell Biology?
Zinc efflux transmembrane transporter activity is important because it controls the amount of free zinc inside cells, which must be kept within a narrow range for normal physiology. When zinc efflux is impaired, intracellular zinc can rise to toxic levels, while extracellular zinc-dependent processes may be starved of zinc. This activity also influences zinc signaling, hormone production, and metal-related disease. The discovery that somatic mutations in SLC30A1 alter zinc efflux and cause primary aldosteronism demonstrates that this molecular function is directly linked to human endocrine disease. In addition, zinc efflux proteins such as TMEM163 and SLC30A10 contribute to cellular metal handling and are studied in the context of neurodegeneration and metal transport disorders.
• Maintains intracellular zinc homeostasis by removing excess zinc from the cytosol.
• Protects cells from zinc toxicity, which can impair mitochondrial function and protein folding.
• Supplies zinc to the extracellular environment for signaling and for secreted proteins.
• Somatic SLC30A1 mutations that alter zinc efflux cause aldosterone-producing adenomas and primary aldosteronism.
• TMEM163 functions as a zinc efflux protein and contributes to cellular zinc regulation.
• SLC30A10 is a manganese efflux transporter whose mechanism informs understanding of related zinc transporters.
• Zinc efflux activity can modulate voltage-gated proton channels and other ion channels through zinc availability.
• Zinc transporters are potential drug targets for endocrine, neurological, and metabolic diseases.
• CRISPR-engineered cell models enable causal testing of zinc efflux gene variants.
• Understanding zinc efflux supports research in cancer, immunity, and metal-related disorders.
What Happens During zinc efflux transmembrane transporter activity?
Zinc binding and recognition
In simple terms: The transporter first grabs a zinc ion inside the cell.
Zinc efflux transporters such as SLC30A1 and TMEM163 contain metal-binding sites that selectively recognize zinc ions. Structural studies of ZnT and ZIP transporters indicate that transmembrane helices form a coordination site for zinc, often involving conserved histidine and aspartate residues. In SLC30A10, putative metal-binding residues in the transmembrane domain are required for transport, and these differ from those of related zinc transporters. This binding step ensures that the transporter selects zinc over other ions and prepares it for translocation.
Conformational change and translocation
In simple terms: The transporter changes shape to push the zinc ion across the membrane.
After zinc binding, the transporter undergoes conformational changes that move the ion from the intracellular side to the extracellular side of the membrane. This alternating-access mechanism is supported by structural comparisons of ZnT and ZIP transporters, which reveal distinct inward- and outward-facing states. In SLC30A10, both transmembrane and cytoplasmic domains are required for efficient manganese efflux, and by analogy, zinc transporters likely use similar domain movements for zinc transport. The energy for this step can come from ion gradients or from the electrochemical potential of zinc itself.
Ion exchange and coupling
In simple terms: Some transporters swap zinc for another ion to move it out.
Mammalian zinc efflux can be coupled to sodium or proton gradients. Ohana et al. demonstrated a sodium-zinc exchange mechanism that mediates zinc extrusion in mammalian cells. This means that the inward movement of sodium or protons can drive the outward movement of zinc, classifying some zinc efflux transporters as secondary active transporters. The coupling ratio and ion selectivity can vary among family members, and structural work continues to define these mechanisms.
Release and resetting
In simple terms: The transporter releases zinc outside and returns to its starting shape.
Once zinc is released on the extracellular side, the transporter returns to its inward-facing conformation to begin another cycle. This resetting step is essential for continuous zinc efflux and is regulated by the availability of intracellular zinc and by protein interactions. In SLC30A1, mutations that alter this cycle can change the amount of zinc efflux and affect aldosterone production. TMEM163 similarly effluxes zinc, and its activity contributes to cellular zinc balance.
Key Genes Involved in GO:0022883 zinc efflux transmembrane transporter activity
The following genes and proteins are experimentally linked to zinc efflux transmembrane transporter activity or to related metal transport mechanisms that inform its study.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC30A1 (ZnT1) | Plasma membrane zinc efflux transporter | Somatic mutations cause aldosterone-producing adenomas and primary aldosteronism. |
| SLC30A10 | Manganese and zinc efflux transporter | Transmembrane and cytoplasmic domains required for metal efflux; model for SLC30A mechanism. |
| TMEM163 | Zinc efflux protein | Demonstrated to efflux zinc; involved in cellular zinc regulation. |
| SLC30A2 (ZnT2) | Zinc efflux into milk and lysosomes | Studied in mammary gland zinc secretion and zinc-related disorders. |
| SLC30A3 (ZnT3) | Vesicular zinc transporter | Packages zinc into synaptic vesicles; relevant to neurotransmission. |
| SLC30A4 (ZnT4) | Zinc efflux in secretory tissues | Associated with zinc deficiency phenotypes in animal models. |
| SLC30A5 (ZnT5) | Zinc efflux in secretory pathway | Implicated in zinc homeostasis and immune function. |
| SLC30A6 (ZnT6) | Golgi zinc transport | Contributes to intracellular zinc distribution. |
| SLC30A7 (ZnT7) | Golgi and secretory zinc efflux | Studied in zinc metabolism and insulin secretion. |
| SLC30A8 (ZnT8) | Pancreatic beta-cell zinc efflux | Risk gene for type 2 diabetes; zinc transport in insulin granules. |
| SLC30A9 (ZnT9) | Intracellular zinc transport | Linked to zinc homeostasis and nuclear function. |
| SLC30A10 | Manganese efflux with zinc-related mechanism | Mutations cause hypermanganesemia; structural studies inform zinc transport. |
| ZIP transporters (SLC39A family) | Zinc influx (opposite direction) | Provide contrast for understanding zinc efflux specificity. |
| Voltage-gated proton channels (HVCN1) | Zinc-sensitive proton transport | Zinc and cholesterol inhibit these channels; arachidonic acid reverses inhibition. |
| TrZnT-1 | Fish plasma membrane zinc efflux transporter | Cloned from fugu; model for vertebrate zinc efflux. |
| MTF-1 | Metal-responsive transcription factor | Regulates expression of metal homeostasis genes including zinc transporters. |
| NRF2 | Oxidative stress transcription factor | May influence zinc transporter expression under stress. |
How Is zinc efflux transmembrane transporter activity Regulated?
Zinc efflux transmembrane transporter activity is regulated at multiple levels. Transcription of zinc transporter genes can be controlled by metal-responsive transcription factors such as MTF-1, which senses intracellular zinc and other metals. Post-translational regulation includes protein trafficking, phosphorylation, and interactions with accessory proteins. For example, SLC30A1 localization and activity can be altered by mutations that affect its transport cycle, leading to changes in aldosterone production. Zinc efflux can also be modulated by the availability of coupling ions such as sodium or protons, as shown for sodium-zinc exchange. In addition, membrane lipids and small molecules can influence zinc transport; arachidonic acid reverses cholesterol and zinc inhibition of voltage-gated proton channels, illustrating crosstalk between zinc and lipid signaling. Together, these mechanisms allow cells to adjust zinc efflux in response to metabolic and environmental cues.
zinc efflux transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC30A1 | Aldosterone-producing adenomas and primary aldosteronism | Knockout or point-mutation adrenal cell lines; aldosterone secretion assays. |
| SLC30A10 | Hypermanganesemia with dystonia, polycythemia, and cirrhosis | Knockout hepatocyte or neuronal cell lines; manganese efflux assays. |
| TMEM163 | Zinc dyshomeostasis and neurological phenotypes | Overexpression and knockout cell models; zinc flux assays. |
| SLC30A8 | Type 2 diabetes risk | Knockout pancreatic beta-cell lines; insulin secretion and zinc imaging. |
| HVCN1 | Zinc-sensitive proton channel biology | Point-mutation and knockout immune cell models; electrophysiology. |
Primary aldosteronism and adrenal adenomas
Somatic mutations in SLC30A1, which encodes the zinc efflux transporter ZnT1, cause aldosterone-producing adenomas and primary aldosteronism. These mutations alter zinc transport activity and lead to increased aldosterone production, highlighting a direct link between zinc efflux and endocrine disease. This discovery has made SLC30A1 a target for functional studies and for understanding how metal transport influences hormone secretion.
Metal transport disorders and neurodegeneration
SLC30A10 is a manganese efflux transporter whose dysfunction causes hypermanganesemia with dystonia, polycythemia, and cirrhosis. Although SLC30A10 primarily transports manganese, its mechanism is closely related to zinc transporters, and studies of its transmembrane and cytoplasmic domains inform understanding of zinc efflux. TMEM163, a zinc efflux protein, is also studied in the context of cellular zinc regulation and may contribute to neurological phenotypes.
Zinc signaling and channel regulation
Zinc efflux influences the concentration of extracellular and intracellular zinc available to modulate ion channels. For example, zinc inhibits human voltage-gated proton channels, and arachidonic acid reverses this inhibition. This crosstalk suggests that changes in zinc efflux activity could affect proton channel function in immune and other cells. Such interactions may be relevant to inflammatory and metabolic conditions where zinc homeostasis is altered.
From zinc efflux transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC30A1 reduce zinc efflux and alter aldosterone production? | SLC30A1 knockout adrenal cell line. |
| Do specific SLC30A1 mutations change zinc transport activity? | Point-mutation knock-in of SLC30A1 variants in adrenal cells. |
| Can TMEM163 overexpression increase zinc efflux? | TMEM163 overexpression in HEK293 or neuronal cells. |
| What domains of SLC30A10 are required for metal efflux? | Domain-deletion and point-mutation knock-in in HeLa or hepatocyte cells. |
| How does zinc efflux affect proton channel activity? | HVCN1 point-mutation or knockout cells with zinc imaging and electrophysiology. |
| What is the role of SLC30A8 in insulin secretion? | SLC30A8 knockout and tagged knock-in pancreatic beta cells. |
How to Study the zinc efflux transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescent zinc imaging | Intracellular and extracellular zinc changes | Measuring zinc efflux in live cells. |
| Radioactive zinc flux | Transport of zinc isotopes across membranes | Quantifying efflux rates in cell lines. |
| Patch-clamp electrophysiology | Ion currents mediated by transporters | Studying electrogenic zinc transport and coupling. |
| Cryo-EM / crystallography | Three-dimensional protein structure | Defining zinc-binding sites and conformational states. |
| Site-directed mutagenesis | Effect of specific residues on transport | Identifying domains required for zinc efflux. |
| CRISPR knockout screens | Genes required for zinc efflux phenotypes | Discovering regulators of zinc homeostasis. |
| RNA-seq / proteomics | Expression of zinc transporters and related genes | Profiling cellular responses to zinc stress. |
| Aldosterone secretion assays | Hormone production in adrenal cells | Linking SLC30A1 mutations to primary aldosteronism. |
Zinc flux assays
Zinc efflux can be measured using radioactive zinc isotopes or fluorescent zinc probes such as FluoZin-3. Cells are loaded with zinc, washed, and the appearance of zinc in the extracellular medium or the loss of intracellular fluorescence is monitored over time. These assays can be performed in wild-type and CRISPR-engineered cells to test the contribution of specific transporters.
Electrophysiology and ion imaging
For electrogenic zinc transporters, patch-clamp and voltage-clamp techniques can record transport currents. Zinc-sensitive microelectrodes and genetically encoded zinc sensors can image real-time zinc changes in live cells. These methods are useful for studying sodium-zinc exchange and proton-coupled transport.
Structural and biochemical approaches
Cryo-electron microscopy and X-ray crystallography have provided structures of ZnT and ZIP transporters, revealing zinc-binding sites and conformational states. Mutagenesis combined with biochemical transport assays identifies residues required for zinc efflux, as shown for SLC30A10. These approaches help define the molecular mechanism of GO:0022883.
CRISPR screens and functional genomics
Genome-wide CRISPR knockout screens can identify genes that regulate zinc efflux and zinc-dependent phenotypes. Cells are challenged with zinc or zinc-sensitive reporters, and sgRNA enrichment or depletion is measured by sequencing. Such screens can uncover novel regulators of zinc efflux transmembrane transporter activity and link them to disease pathways.
How CRISPR Can Be Used to Study GO:0022883 zinc efflux transmembrane transporter activity
Knockout
CRISPR knockout of zinc efflux genes such as SLC30A1, SLC30A10, or TMEM163 can abolish transporter activity and reveal its contribution to cellular zinc homeostasis and disease phenotypes. For example, SLC30A1 knockout adrenal cells can be used to test whether loss of zinc efflux alters aldosterone production. Knockout models are also useful for validating findings from CRISPR screens.
Point Mutation
Point mutations identified in patient tumors, such as those in SLC30A1, can be introduced into cell lines using CRISPR base editing or homology-directed repair to test their effect on zinc transport. This approach distinguishes driver mutations from passenger variants and helps define structure-function relationships in zinc efflux proteins.
Knock-in
Knock-in of tagged or reporter versions of zinc transporters allows visualization and quantification of protein localization and trafficking. For example, a fluorescently tagged SLC30A1 knock-in can be used to monitor its movement to the plasma membrane and its response to zinc. Knock-in of disease-associated variants can create isogenic models for drug testing.
Overexpression
Overexpression of zinc efflux transporters such as TMEM163 or SLC30A1 can increase zinc export and lower intracellular zinc, providing a gain-of-function system to study downstream effects. Overexpression models are useful for testing whether increased zinc efflux is sufficient to alter signaling pathways or hormone secretion.
How EDITGENE Supports zinc efflux transmembrane transporter activity Research
Researchers studying zinc efflux transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in zinc homeostasis or disease. CRISPR-based cell models provide a controlled way to test loss-of-function, gain-of-function, and patient-specific variants in relevant cell types. EDITGENE offers a suite of services to generate and characterize such models, from knockout to knock-in and library screening, supported by bioinformatics analysis.
Contact EDITGENE today to design your custom CRISPR model for zinc efflux transmembrane transporter activity research.
Frequently Asked Questions About zinc efflux transmembrane transporter activity
What is zinc efflux transmembrane transporter activity?
It is the molecular function defined by GO:0022883, which enables the transfer of zinc ions from the inside of a cell to the outside across a membrane.
What genes are involved in zinc efflux transmembrane transporter activity?
Key genes include SLC30A1 (ZnT1), SLC30A10, TMEM163, and other SLC30A/ZnT family members, as well as related proteins studied in metal transport.
Which GO ID represents zinc efflux transmembrane transporter activity?
The GO ID is GO:0022883, with the synonym zinc efflux permease activity.
How is zinc efflux measured in the lab?
Common methods include fluorescent zinc imaging, radioactive zinc flux assays, electrophysiology, and CRISPR-based functional screens.
What diseases are linked to defects in zinc efflux?
Somatic SLC30A1 mutations cause aldosterone-producing adenomas and primary aldosteronism, and SLC30A10 dysfunction causes hypermanganesemia with dystonia and other symptoms.
What is the difference between zinc efflux and zinc influx?
Zinc efflux moves zinc out of the cell via transporters such as SLC30A1, while zinc influx moves zinc into the cell via ZIP/SLC39A transporters.
Can CRISPR be used to study zinc efflux genes?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of zinc efflux genes in cell-based assays.
What is the role of SLC30A1 in primary aldosteronism?
Somatic mutations in SLC30A1 alter zinc efflux and lead to aldosterone-producing adenomas and primary aldosteronism.
How does TMEM163 contribute to zinc transport?
TMEM163 has been shown to efflux zinc and is involved in cellular zinc regulation.
What experimental models are suitable for studying zinc efflux?
Adrenal, neuronal, hepatic, and pancreatic cell lines with CRISPR edits, combined with zinc flux assays and hormone or metal sensitivity readouts, are commonly used.
Conclusion
GO:0022883, zinc efflux transmembrane transporter activity, defines a fundamental molecular function that protects cells from zinc toxicity and maintains zinc homeostasis. The SLC30A/ZnT family and related proteins such as TMEM163 and SLC30A10 carry out this activity, and their dysfunction is linked to endocrine and metal transport diseases. Understanding the mechanism, regulation, and disease relevance of zinc efflux requires integrated structural, biochemical, and genetic approaches. CRISPR-engineered cell models provide a powerful way to test the causal role of zinc efflux genes and variants. By combining knockout, point-mutation, knock-in, and overexpression strategies with functional assays, researchers can dissect how zinc efflux contributes to physiology and disease, and identify new targets for therapeutic intervention.
References
- 1. Rege J et al.. 2023. Somatic SLC30A1 mutations altering zinc transporter ZnT1 cause aldosterone-producing adenomas and primary aldosteronism.. Nat Genet 55(10):1623-1631 PMID: 37709865
- 2. Sanchez VB et al.. 2019. Transmembrane 163 (TMEM163) protein effluxes zinc.. Arch Biochem Biophys 677:108166 PMID: 31697912
- 3. Zogzas CE et al.. 2016. Structural Elements in the Transmembrane and Cytoplasmic Domains of the Metal Transporter SLC30A10 Are Required for Its Manganese Efflux Activity.. J Biol Chem 291(31):15940-57 PMID: 27307044
- 4. Zogzas CE et al.. 2018. Putative metal binding site in the transmembrane domain of the manganese transporter SLC30A10 is different from that of related zinc transporters.. Metallomics 10(8):1053-1064 PMID: 29989630
- 5. Xie Q et al.. 2025. A structural perspective of transmembrane transport of zinc by ZnT and ZIP transporters.. J Struct Biol 217(3):108235 PMID: 40706969
- 6. Balesaria S et al.. 2006. Identification, cloning and characterization of a plasma membrane zinc efflux transporter, TrZnT-1, from fugu pufferfish (Takifugu rubripes).. Biochem J 394(Pt 2):485-93 PMID: 16212555
- 7. Ohana E et al.. 2004. A sodium zinc exchange mechanism is mediating extrusion of zinc in mammalian cells.. J Biol Chem 279(6):4278-84 PMID: 14581475
- 8. Han S et al.. 2023. Arachidonic acid reverses cholesterol and zinc inhibition of human voltage-gated proton channels.. J Biol Chem 299(7):104918 PMID: 37315791
